About Riddhima Chakraborty
Riddhima is a financial journalist with a passion for analyzing financial instruments. With a master's degree in economics, she helps investors make informed investment decisions through her insightful commentaries.
Recent Articles By Riddhima Chakraborty
1 Health Care Stocks Insiders Are Buying up Right Now
CVS Health (CVS) insiders have been scooping up its shares lately, indicating the company’s better prospects. Moreover, Wall Street analysts see a more than 30% upside potential in the stock. Given its strong fundamentals, CVS might be an ideal investment now. Keep reading…
This 1 Stock Could Sink Your Portfolio if You Don't Sell It Now
Although Norwegian Cruise Line (NCLH) saw bookings surging in the early months of this year, it is yet to achieve pre-pandemic occupancy, which looks difficult to achieve in the near term considering the uncertain macro environment. The stock has lost more than 20% in 2022. And given its bleak fundamentals, NCLH might be best avoided. Keep reading…
Is It Too Late to Make Money on ABT Stocks This Fall?
Despite the uncertain macro environment, Abbott (ABT) increased its adjusted EPS guidance for 2022. Wall Street analysts expect it to rally more than 20% in the near term. However, the stock is down 30% year-to-date. So, let's find out if it is the right time to invest in ABT…
1 Stock You'll Be Thankful You Didn't Buy in 2022
Used car dealer Carvana's (CVNA) bottom line has declined substantially in the last reported quarter and is lying in the red. Analysts have recently downgraded CVNA. Moreover, it has lost almost 95% in 2022. It seems best to steer clear of CVNA this year. Read on…
Is Lucid Stock Worth Looking at This Week?
Electric vehicle (EV) maker Lucid Group (LCID) has been introducing new technologies to grab market share. However, the stock lost more than 65% in 2022 on concerns over its weak fundamentals. So, is LCID worth your attention? Let’s find out…
Don't Count on a Comeback for AMC Stock
Meme traders darling from the last year, AMC Entertainment (AMC) is trading near its 52-week low of $5.47 and has lost more than 75% in 2022. And given its bleak fundamentals, the stock might not be able to sustain its gains, even if it manages a rally. Let’s discuss its prospects in detail…
AMD Stock: Don’t Buy Into It in Q4
Semiconductor company Advanced Micro Devices (AMD) slashed its revenue guidance for the upcoming quarter in the face of declining chip demand. The stock has lost more than 60% in 2022. Moreover, its bottom line has declined significantly. So, it could be best to avoid AMD this year. Keep reading…
2 Stocks Under $40 to Buy in Q4
The odds of another 75-bps rate hike are rising, with inflation showing no signs of slowing down. However, a decent start to the corporate earnings season could offer some relief for the stock market. We think investors could consider buying quality stocks Verizon Communications (VZ) and AudioCodes (AUDC), which are currently trading under $40. Keep reading…
This Pharmaceutical Stock Is Still a Smart Buy in 2022
Pfizer’s (PFE) co-developed COVID-19 vaccine booster for children, which recently got Emergency Use Authorization from the U.S. FDA, could boost its share price. The stock had witnessed significant attention during the pandemic and could still be worth owning. Let’s discuss this in detail…